Company Directory / Pharmaceuticals
Public · NASDAQ:RETAFor profitPharmaceuticalsPlano, Texas, United States
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Reata Pharmaceuticals has been acquired by Biogen. Please follow along there for the latest news. This page is no longer updated or monitored.
Size
251-500 people: larger than 92% of companies with a size listed. 103 people list it on LinkedIn.
Age
24 years old.
Reach
No web traffic ranking listed. 23,196 followers on LinkedIn.
BiopharmaBiotechnologyPharmaceuticalBiopharmaceuticalsResearchClinical OperationsBiotechnology
biopharmaceuticalsresearchclinical operationsbiotechnologylife sciencesbiotechnology: pharmaceutical preparationshealth carepharmaceutical manufacturingpharmaceutical and medicine manufacturingserious diseasesdesigner drugsmedical innovationbiotech companybiotech manufacturingbiotech for rare diseasesbiotech r&d
Google Search ConsoleApple Business ManagerAWS CloudAmazon CloudFrontZendesk for ServiceAmazon Route 53Apple School ManagerMicrosoft Email ProvidersMicrosoft Exchange OnlineOutlookMicrosoft ExchangeMicrosoft 365Microsoft 365 Apps & ServicesSmartsheetNetSuiteAdobeAmazon AWSDocuSign
Funding, as listed
$2.0B raised in total
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Everything the source datasets list about Reata Pharmaceuticals, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Classification
About this record
Growth, as the source summarises it
Reata Pharmaceuticals may be growing as it was listed among companies with the best 1-year total returns as of mid-August. This performance indicator suggests that the company's stock value has appreciated, reflecting investor confidence and potentially positive financial health. The inclusion in a list that highlights top returns is indicative of a strong market performance relative to peers, which can be a result of various growth factors such as successful drug developments, effective business strategies, or favorable market conditions.
Summaries written by the source dataset, not by us, and not checked.
Pharmaceuticals in United States.
PCI Pharma ServicesPhiladelphia · 5001-10000 people · 71k followersAAmneal PharmaceuticalsBridgewater · 5001-10000 people · 225k followersssanofi-aventis U.SBridgewater · 10001+ peopleFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.